Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Oliver Tomkins

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Frontiers in Oncology|November 19, 2024
Review of BCL2 inhibitors for the treatment of Waldenström's macroglobulinaemia and non-IgM lymphoplasmacytic lymphomaOliver Tomkins, Shirley D'Sa
Current Opinion in Neurology|June 11, 2024
Recent insights into haematology and peripheral nerve diseaseOliver Tomkins, Michael P Lunn
Hematology/Oncology Clinics of North America|June 29, 2023
Investigation and Management of Immunoglobulin M- and Waldenström-Associated Peripheral NeuropathiesOliver Tomkins, Veronique Leblond, Michael P Lunn, et al.
Clinical Rehabilitation|July 4, 2025
A scoping review: POEMS syndrome (Polyneuropathy, Organomegaly, Endocrinopathy, Monoclonal plasma cell disorder and Skin Changes), physical recovery, and rehabilitationLucy Johnson, Shirley D'Sa, Gita Ramdharry, et al.
BMJ Case Reports|April 16, 2025
Successful assisted pregnancy outcome in a patient with POEMS syndromeAbhishek Malakar, Shaazma Zainab Naqvi, Oliver Tomkins, et al.
Blood Advances|January 22, 2026
Efficacy of Radiotherapy and Role of Adjunctive Immunochemotherapy in POEMS Syndrome with Solitary PlasmacytomaGrace Lau, Cavitha Vivekananthan, Oliver Tomkins, et al.
British Journal of Haematology|March 23, 2026
Front-line systemic treatment outcomes in POEMS syndromeOliver Tomkins, Jahanzaib Khwaja, Shiwen Koay, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|May 20, 2026
Acquired vitamin B6 deficiency in POEMS: a marker of disease activity and cause of neuropathy?Oliver Tomkins, Simon Alexander Samuel Pope, Youssef Khalil, et al.
British Journal of Haematology|July 18, 2020
Clinical outcomes and risk factors for severe COVID-19 in patients with haematological disorders receiving chemo- or immunotherapyThomas A Fox, Ethan Troy-Barnes, Amy A Kirkwood, et al.
Blood|November 5, 2020
Real-world experience with caplacizumab in the management of acute TTPTina Dutt, Rebecca J Shaw, Matthew Stubbs, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Frontiers in Oncology|November 19, 2024
Review of BCL2 inhibitors for the treatment of Waldenström's macroglobulinaemia and non-IgM lymphoplasmacytic lymphomaOliver Tomkins, Shirley D'Sa
Current Opinion in Neurology|June 11, 2024
Recent insights into haematology and peripheral nerve diseaseOliver Tomkins, Michael P Lunn
Hematology/Oncology Clinics of North America|June 29, 2023
Investigation and Management of Immunoglobulin M- and Waldenström-Associated Peripheral NeuropathiesOliver Tomkins, Veronique Leblond, Michael P Lunn, et al.
Clinical Rehabilitation|July 4, 2025
A scoping review: POEMS syndrome (Polyneuropathy, Organomegaly, Endocrinopathy, Monoclonal plasma cell disorder and Skin Changes), physical recovery, and rehabilitationLucy Johnson, Shirley D'Sa, Gita Ramdharry, et al.
BMJ Case Reports|April 16, 2025
Successful assisted pregnancy outcome in a patient with POEMS syndromeAbhishek Malakar, Shaazma Zainab Naqvi, Oliver Tomkins, et al.
Blood Advances|January 22, 2026
Efficacy of Radiotherapy and Role of Adjunctive Immunochemotherapy in POEMS Syndrome with Solitary PlasmacytomaGrace Lau, Cavitha Vivekananthan, Oliver Tomkins, et al.
British Journal of Haematology|March 23, 2026
Front-line systemic treatment outcomes in POEMS syndromeOliver Tomkins, Jahanzaib Khwaja, Shiwen Koay, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|May 20, 2026
Acquired vitamin B6 deficiency in POEMS: a marker of disease activity and cause of neuropathy?Oliver Tomkins, Simon Alexander Samuel Pope, Youssef Khalil, et al.
British Journal of Haematology|July 18, 2020
Clinical outcomes and risk factors for severe COVID-19 in patients with haematological disorders receiving chemo- or immunotherapyThomas A Fox, Ethan Troy-Barnes, Amy A Kirkwood, et al.
Blood|November 5, 2020
Real-world experience with caplacizumab in the management of acute TTPTina Dutt, Rebecca J Shaw, Matthew Stubbs, et al.
Pageof 2